Literature DB >> 11680616

Inhibition of cyclooxygenase-2 attenuates urinary prostanoid excretion without affecting renal renin expression.

M C Kammerl1, R M Nüsing, H W Seyberth, G A Riegger, A Kurtz, B K Krämer.   

Abstract

This study aimed to assess the impact of cyclooxygenase-2 (COX-2) on the secretion and expression of renin in the kidney cortex. For this purpose renocortical COX-2 expression was moderately stimulated by a low-salt diet or strongly stimulated (increase in mRNA about fivefold) by the combination of a low-salt diet and the angiotensin-I-converting enzyme inhibitor ramipril in male Sprague-Dawley rats. None of these manoeuvres changed medullary COX-2 expression or cortical or medullary COX-1 expression. Treatment with low salt plus ramipril but not with low salt alone led to a three- to fourfold increase of the urinary output of all major prostanoids. The selective COX-2 inhibitor rofecoxib (10 mg/kg per day) markedly lowered basal urinary prostanoid excretion and blunted the stimulation of prostanoid excretion during treatment with low salt plus ramipril. The stimulation of renin secretion by the low-salt diet but not by low salt plus ramipril was attenuated by rofecoxib. The low-salt diet led to a moderate increase of renin gene expression, and additional treatment with ramipril caused a 15-fold increase of renin mRNA. However, no effect of rofecoxib on renin gene expression was observed in any group. These findings suggest that stimulation of COX-2 in the renal cortex leads to the increased formation of all major prostanoids. COX-2-derived prostanoids may play a role in the regulation of renin secretion but not in renin gene expression during the intake of a low-salt diet. However, no major relevance of COX-2-derived prostanoids to renin secretion or renin gene expression during ramipril treatment or a combination of ramipril and a low-salt diet was found.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680616     DOI: 10.1007/s004240100616

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  11 in total

Review 1.  Tubular control of renin synthesis and secretion.

Authors:  Jurgen Schnermann; Josephine P Briggs
Journal:  Pflugers Arch       Date:  2012-06-05       Impact factor: 3.657

Review 2.  Convergence of major physiological stimuli for renin release on the Gs-alpha/cyclic adenosine monophosphate signaling pathway.

Authors:  Soo Mi Kim; Josephine P Briggs; Jurgen Schnermann
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

3.  Prostaglandin E2 EP3 receptor regulates cyclooxygenase-2 expression in the kidney.

Authors:  Carlos P Vio; Mariana Quiroz-Munoz; Catherina A Cuevas; Carlos Cespedes; Nicholas R Ferreri
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-23

4.  Everolimus treatment downregulates renocortical cyclooxygenase-2 expression in the rat kidney.

Authors:  Klaus Höcherl; Corina Hensel; Bettina Ulbricht; Bernhard K Krämer
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

Review 5.  The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function.

Authors:  Torrance Green; Alexis A Gonzalez; Kenneth D Mitchell; L Gabriel Navar
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

Review 6.  Synthesis and secretion of renin in mice with induced genetic mutations.

Authors:  Jurgen Schnermann; Josephine P Briggs
Journal:  Kidney Int       Date:  2012-01-18       Impact factor: 10.612

7.  Augmented cyclooxygenase-2 effects on renal function during varying states of angiotensin II.

Authors:  Torrance Green; Jorge Rodriguez; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2010-07-28

8.  Cyclo-oxygenase-2 inhibition increases blood pressure in rats.

Authors:  Klaus Höcherl; Dierk Endemann; Martin C Kammerl; Horst F Grobecker; Armin Kurtz
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

9.  Differential regulation of renin and Cox-2 expression in the renal cortex of C57Bl/6 mice.

Authors:  Charlotte Wagner; Helga Vitzthum; Hayo Castrop; Karl Schumacher; Michael Bucher; Sybille Albertin; Thomas M Coffman; William J Arendshorst; Armin Kurtz
Journal:  Pflugers Arch       Date:  2003-09-19       Impact factor: 3.657

Review 10.  Pharmacokinetics of rofecoxib: a specific cyclo-oxygenase-2 inhibitor.

Authors:  Neal M Davies; Xiao W Teng; Neil M Skjodt
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.